Author

H. Al-Ali

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. D. Axtman· 2 shared C. I. Wells· 2 shared D. H. Drewry· 2 shared D. K. Treiber· 2 shared D. M. Andrews· 2 shared K. S. Saikatendu· 2 shared M. Frederiksen· 2 shared P. Ettmayer· 2 shared

Activity by Year

2017-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. D. Axtman

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Empagliflozin reduces renal lipotoxicity in experimental Alport syndrome

M. Ge, J. Molina, J. J. Kim, S. K. Mallela, A. Ahmad, J. Varona Santos, H. Al-Ali, A. Mitrofanova, K. Sharma, F. Fontanesi, S. Merscher, A. Fornoni

This study shows empagliflozin reduces renal lipotoxicity and improves kidney function in experimental Alport syndrome by shifting energy substrates from glucose to fatty acids in podocytes.

bioRxiv · Oct 4, 2022Cell Biology

The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification

C. I. Wells, H. Al-Ali, D. M. Andrews, C. R. M. Asquith, A. D. Axtman, M. Chung, I. Dikic, D. Ebner, J. Elkins, P. Ettmayer, C. Fischer, M. Frederiksen, N. S. Gray, S. B. Hatch, S. Knapp, , D. H. Drewry

The paper introduces the Kinase Chemogenomic Set (KCGS), a curated collection of 187 selective kinase inhibitors covering 215 human kinases, for use in cell-based screens.

bioRxiv · Dec 22, 2019Cell Biology

Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions

D. H. Drewry, C. I. Wells, D. M. Andrews, R. Angell, H. Al-Ali, A. D. Axtman, S. J. Capuzzi, J. M. Elkins, P. Ettmayer, M. Frederiksen, O. Gileadi, N. Gray, A. Hooper, S. Knapp, S. Laufer, , T. M. Willson

The paper shares progress on a kinase chemogenomic set, releases inhibitor profiling data, and calls for community collaboration to complete the set.

bioRxiv · Jan 31, 2017Pharmacology & Toxicology